USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE

摘要

Use of tetrapeptide-3 GEKG or pentapeptide-3 GEKGF for treating degenerative joint disease is disclosed. A pharmaceutical composition comprising an effective amount of tetrapeptide-3 GEKG or pentapeptide-3 GEKGF and a pharmaceutically acceptable carrier is also disclosed.